SCHEMBL2467429

SCHEMBL2467429

COc1ccc(-c2ncccn2)nc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 2/20 0.59
DYRK1A Q13627 1/20 0.48
NPC1 O15118 7/20 0.46
RAB9A P51151 6/20 0.46
CYP19A1 P11511 1/20 0.46
L3MBTL1 Q9Y468 3/20 0.45
LMNA P02545 2/20 0.45
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
HSP90AA1 P07900 1/20 0.44
PKM P14618 1/20 0.44
MAPT P10636 2/20 0.42
TNKS O95271 1/20 0.42
HTT P42858 1/20 0.42
PPP1CA P62136 1/20 0.42
CCR1 P32246 1/20 0.42
CCR5 P51681 1/20 0.42
CCR8 P51685 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3147993 0.84 CA12 (0.50) CLK4NPC1RAB9AALDH1A1RXFP1
SCHEMBL30335253 0.84 CA12 (0.50) CLK4NPC1RAB9AALDH1A1RXFP1
SCHEMBL25195228 0.84 LMNA (0.54) NPC1RAB9AL3MBTL1LMNAALDH1A1
SCHEMBL29419008 0.84 LMNA (0.54) NPC1RAB9AL3MBTL1LMNAALDH1A1
SCHEMBL1443857 0.78 L3MBTL1 (0.59) NPC1RAB9AL3MBTL1LMNAALDH1A1
SCHEMBL13341651 0.78 NPC1 (0.62) DYRK1ANPC1RAB9AL3MBTL1LMNA
SCHEMBL17992232 0.77 NPC1 (0.44) CLK4NPC1RAB9AALDH1A1TNKS
SCHEMBL13330991 0.77 NPC1 (0.46) CLK4NPC1RAB9AMAPT
SCHEMBL14355082 0.76 NPC1 (0.56) NPC1RAB9ASMN1; SMN2RXFP1CYP1A2
SCHEMBL16656143 0.75 CCR1 (0.67) NPC1RAB9AALDH1A1TDP1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2370426-A1 N-{[(IR,4S,6R-3-(2-PYRIDINYLCARBONYL)-3-AZABICYCLO [4.1.0]HEPT-4-YL]METHYL}-2-HETEROARYLAMINE DERIVATIVES AND USES THEREOF Glaxo Group Limited (GB) 2011-10-05 EP disclosed
WO-2010063663-A1 N-{[(IR,4S,6R-3-(2-PYRIDINYLCARBONYL)-3-AZABICYCLO [4.1.0]HEPT-4-YL] METHYL}-2-HETEROARYLAMINE DERIVATIVES AND USES THEREOF GLAXO GROUP LIMITED (GB) 2010-06-10 WO disclosed